Glycopyrrolate And Indacaterol Suppliers & Bulk Manufacturers

Available Forms: Subcutaneous injection

Available Strengths: 27.5 mcg + 15.6 mcg or 85 mcg + 43 mcg

Reference Brands: Utibron Neohaler(US), Ultibro Breezhaler(EU)

Category: Respiratory Disorder

Glycopyrrolate and Indacaterol is available in Subcutaneous injection and strengths such as 27.5 mcg + 15.6 mcg or 85 mcg + 43 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Glycopyrrolate and Indacaterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Glycopyrrolate and Indacaterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Glycopyrrolate and indacaterol is a fixed-dose combination used in the maintenance treatment of chronic obstructive pulmonary disease (COPD). This dual bronchodilator combines a long-acting muscarinic antagonist (LAMA) with a long-acting beta-agonist (LABA) to improve lung function and reduce COPD symptoms. Available under brand names like Ultibro Breezhaler in the EU and previously Utibron Neohaler in the US, it is delivered via dry powder inhaler (DPI) for once-daily or twice-daily use. The combination enhances airway relaxation, reduces breathlessness, and supports better respiratory control. It is not intended for asthma or acute bronchospasm relief.